(I-MED Pharma) The following tale was told to me one dark, Halloween night, deep in the warehouse of I-MED Pharma and is written here in almost the exact words in which I heard it. The storyteller claimed to have found the legend among some old papers, buried deep among the shipping boxes. In the heart […]
(I-MED Pharma) Do you have dry eyes? If so, you’re not alone, as approximately 30% of Canadians suffer from dry eye disease. Are your dry eyes caused by Meibomian gland dysfunction (MGD)? A significantly higher proportion of dry eye disease patients show signs of evaporative dry eye resulting from MGD, with 86% of qualified patients […]
(I-MED Pharma) Author’s Note: Antonio Vivaldi’s “The Four Seasons” is a perfect listening companion to this read. Dry eye disease can be a chronic condition with discomforting symptoms occurring year-round. Because certain environmental factors can affect how the eyes feel and contribute to disease progression, listed below are some suggestions for managing dry eye during […]
(I-MED Pharma) Dry eye is a growing concern. With an estimated 30% of the Canadian population suffering from this disease, it’s important to remember that it can affect anyone, of any age. Booking regular screenings with an eye care professional, taking preventative measures such as limiting screen-time, and incorporating proper dry eye management solutions is […]
(I-MED Pharma) The face of dry eye is changing, no longer the traditional image of a post-menopausal woman, because this prevalent disease can affect anyone – from preteens to the elderly – in part due to the increasing use of screens in our digital world. Effective diagnosis, treatment, and subsequent at-home management of dry eye […]
(I-MED Pharma) Updated May 2023: Since the initial release of this blog post, I-VU® OMEGA now contains increased levels of DPA. Our daily diet has an impact on our overall health and in the prevention of diseases, and with that in mind, I-MED Pharma is excited to introduce its newest nutritional supplement, I-VU® OMEGA-3! This […]
(I-MED Pharma) Hey gamers, didn’t see that sniper lurking across the map? Maybe it’s because you’ve got dry eyes! Next time, manage those dry eye symptoms and protect those in-game stats with the help of I-MED Pharma to experience a better and more comfortable gaming experience. Initiating Dry Eye Let’s face it, staring at a […]
(I-MED Pharma) Did you know that woman over the age of 50 have a higher risk of dry eye problems? According to the American Academy of Ophthalmology, dry eye disease (DED) affects over 3.2 million American women middle aged and over.[1]Hormonal changes associated with menopause make dry eye disease more prevalent among women in this […]
Montreal, February 3, 2022 (Globe Newswire) With the recent launch of its line of dry eye diagnostics, management, and treatment solutions into the United States, I-MED Pharma USA has partnered with DryEye Rescue of Boca Raton, Florida to distribute and market their unique and innovative dry eye product portfolio. DryEye Rescue will help raise awareness […]
January 24, 2022 I-MED Pharma continues to grow and expand! We are pleased to announce that our corporate office is moving to the new location indicated below, effective January 31, 2022. 7190 Frederick Banting Rd. St. Laurent, QC H4S 2A1 Our new headquarters will allow us to better serve our growing clientele, with a larger […]
(I-MED Pharma) It’s the end of the year, one of our busiest yet, and this holiday season we would like to take a moment to reflect on all the positive events that have happened over the last 12 months at I-MED Pharma. As always, we are continuously #advancingthescienceofdryeye, most recently through the publication of two […]
Montreal, December 15, 2021 (GLOBE NEWSWIRE) NTC Srl, R&D driven pharmaceutical company with headquarters in Italy, and I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that I-DEFENSE®, a long-lasting, lubricating ointment with lanolin and mineral oil indicated for the relief of dry eyes and lagophthalmos symptoms has been […]